Section 34-23-32.2

Revocation, suspension, etc., of license or certificate; non-disciplinary administrative penalty.

Any requirements established by the FDA Guidelines in the Drug Quality and Security Act shall be adhered to by the affected parties. The board may permit any manufacturer, manufacturer affiliate, bottler, packager, repackager, third party logistic provider, wholesale drug distributor, private label distributor, or pharmacy business identified in the supply chain of any drugs, legend drugs, medicines, chemicals, or poisons for medicinal purposes. The board, by rule, shall establish fees for permits issued under this section and fines for violations of this section. Proceeds received by the board from fees levied and fines collected pursuant to this section shall be used by the board to fund the costs of permitting, inspecting, and investigating any business permitted pursuant to this section.

(Act 2017-422, §2.)